Variant report
Variant | rs5012561 |
---|---|
Chromosome Location | chr2:55742032-55742033 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:55659643..55661172-chr2:55741607..55744341,2 | MCF-7 | breast: | |
2 | chr2:55741679..55743940-chr2:55745074..55747931,2 | K562 | blood: | |
3 | chr2:55495061..55497055-chr2:55740247..55742964,2 | MCF-7 | breast: | |
4 | chr2:55740884..55742822-chr2:55843227..55845306,2 | MCF-7 | breast: | |
5 | chr2:55735103..55738045-chr2:55741187..55743259,2 | K562 | blood: | |
6 | chr2:55740661..55742965-chr2:55745170..55747849,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000085760 | Chromatin interaction |
ENSG00000272606 | Chromatin interaction |
ENSG00000163001 | Chromatin interaction |
ENSG00000138041 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1013138 | 0.82[JPT][hapmap] |
rs12617627 | 0.90[CHB][hapmap];0.89[JPT][hapmap];0.96[YRI][hapmap];0.84[AFR][1000 genomes];0.90[ASN][1000 genomes] |
rs12618859 | 0.83[JPT][hapmap];0.96[YRI][hapmap] |
rs12619903 | 0.82[CEU][hapmap];0.92[YRI][hapmap] |
rs12986444 | 0.84[AFR][1000 genomes] |
rs12986587 | 0.81[CHB][hapmap];0.83[JPT][hapmap];0.81[ASN][1000 genomes] |
rs12992408 | 0.90[CHB][hapmap];0.94[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];0.96[ASN][1000 genomes] |
rs12992827 | 0.82[ASN][1000 genomes] |
rs12993624 | 0.89[JPT][hapmap];0.88[YRI][hapmap];0.82[AFR][1000 genomes] |
rs12993642 | 0.82[ASN][1000 genomes] |
rs12998664 | 0.84[JPT][hapmap] |
rs12998780 | 0.80[JPT][hapmap] |
rs12998925 | 0.81[EUR][1000 genomes] |
rs12999506 | 0.83[AFR][1000 genomes] |
rs12999680 | 0.89[AFR][1000 genomes];0.90[ASN][1000 genomes] |
rs12999966 | 0.82[CEU][hapmap];0.92[YRI][hapmap] |
rs13001425 | 0.84[JPT][hapmap];0.87[YRI][hapmap] |
rs13005678 | 0.99[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs13006502 | 0.91[AFR][1000 genomes];0.90[ASN][1000 genomes] |
rs13009239 | 0.87[ASN][1000 genomes] |
rs13009447 | 0.83[CHB][hapmap];0.83[JPT][hapmap];0.86[YRI][hapmap] |
rs13009906 | 1.00[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13010217 | 0.89[JPT][hapmap];0.96[YRI][hapmap];0.84[AFR][1000 genomes] |
rs13014898 | 0.86[CHB][hapmap];0.95[JPT][hapmap];0.96[YRI][hapmap];0.91[AFR][1000 genomes];0.94[ASN][1000 genomes] |
rs13015018 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs13015030 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes] |
rs13015744 | 0.81[JPT][hapmap] |
rs13021958 | 1.00[YRI][hapmap];0.89[AFR][1000 genomes];0.93[ASN][1000 genomes] |
rs13025331 | 0.89[JPT][hapmap];0.96[YRI][hapmap];0.84[AFR][1000 genomes] |
rs13027095 | 0.82[AFR][1000 genomes] |
rs13027853 | 0.85[AFR][1000 genomes];0.93[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs13032503 | 1.00[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.99[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs1318672 | 0.91[CHB][hapmap];0.95[JPT][hapmap];0.88[YRI][hapmap];0.87[AFR][1000 genomes];0.91[ASN][1000 genomes] |
rs17737233 | 0.84[JPT][hapmap] |
rs1822513 | 0.81[CHB][hapmap];0.84[JPT][hapmap];0.87[YRI][hapmap] |
rs2291336 | 0.84[JPT][hapmap] |
rs34013926 | 0.87[AFR][1000 genomes];0.91[ASN][1000 genomes] |
rs34143512 | 0.91[AFR][1000 genomes];0.94[ASN][1000 genomes] |
rs34679603 | 0.80[ASN][1000 genomes] |
rs35189503 | 0.80[ASN][1000 genomes] |
rs3791654 | 0.89[JPT][hapmap];0.92[YRI][hapmap];0.81[AFR][1000 genomes] |
rs3828238 | 0.84[JPT][hapmap] |
rs4312532 | 0.86[CEU][hapmap];0.95[JPT][hapmap];0.80[EUR][1000 genomes] |
rs4322879 | 0.96[CEU][hapmap];0.81[JPT][hapmap];0.96[YRI][hapmap];0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.92[EUR][1000 genomes] |
rs56122729 | 0.83[ASN][1000 genomes] |
rs66545054 | 0.89[AFR][1000 genomes];0.92[ASN][1000 genomes] |
rs6737995 | 0.84[JPT][hapmap];0.96[YRI][hapmap];0.83[AFR][1000 genomes] |
rs6757006 | 0.95[CHB][hapmap];1.00[JPT][hapmap];0.96[YRI][hapmap];0.89[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs7575170 | 0.81[CEU][hapmap];0.85[JPT][hapmap];0.92[YRI][hapmap] |
rs8080 | 0.91[CHB][hapmap];1.00[JPT][hapmap];0.87[YRI][hapmap];0.94[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1006170 | chr2:55530179-55809251 | Strong transcription Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 29 gene(s) | inside rSNPs | diseases |
2 | nsv520581 | chr2:55622825-55903016 | Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 42 gene(s) | inside rSNPs | diseases |
3 | nsv531374 | chr2:55653723-56299784 | Enhancers Weak transcription Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 56 gene(s) | inside rSNPs | diseases |
4 | nsv874160 | chr2:55713102-55828974 | Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 11 gene(s) | inside rSNPs | diseases |
5 | nsv525434 | chr2:55716650-55841640 | Weak transcription Enhancers Strong transcription Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 11 gene(s) | inside rSNPs | diseases |
6 | nsv834080 | chr2:55741036-55927928 | Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 30 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:55739000-55745600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr2:55739000-55745800 | Weak transcription | Brain Angular Gyrus | brain |
3 | chr2:55739000-55745800 | Weak transcription | Thymus | Thymus |
4 | chr2:55739000-55745800 | Weak transcription | NHEK | skin |
5 | chr2:55741800-55745800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |